Edit

Mirati Therapeutics

http://mirati.com/

Last activity: 10.11.2023

Tags:BioTechDesignInformationLifeMediaMedTechScienceSocial

Our mission is to discover, design & deliver breakthrough therapies to transform the lives of patients with cancer and their loved ones. http://bit.ly/3lFIWB0

Mentions

Location: United States, California, San Diego

Employees: 201-500

Founded date: 1995

Twitter

Facebook

Investors 2

Date	Name	Website
-	Avoro Capi...	avorocapit...
-	Internatio...	ibtplc.com

Mentions in press and media 21

Date	Title	Description	Source
10.11.2023	The first vaccine for the increasingly prevalent chikungunya...	Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech ne...	statnews.c...
06.01.2023	Mirati Therapeutics Reports Inducement Grant Under NASDAQ Li...	SAN DIEGO, Jan. 6, 2023 /PRNewswire/ -- Mirati Therapeutics, Inc. MRTX, a clinical-stage targeted on...	einpresswi...
17.11.2021	Mirati Therapeutics Announces Submission of Investigational ...	SAN DIEGO, Nov. 17, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage ...	marketscre...
11.11.2021	Mirati Therapeutics Announces Pricing of Public Offering of ...	SAN DIEGO, Nov. 10, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX), a clinical-stage ...	marketscre...
10.11.2021	Mirati Therapeutics Announces Proposed Public Offering of Co...	SAN DIEGO, Nov. 9, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (Nasdaq: MRTX) a clinical-stage on...	marketscre...
08.10.2021	Mirati teams with Sanofi on PhI/II trial for KRAS treatme...	Charles Baum Mirati and Sanofi on Friday announced their new non-exclusive, clinical collab...	endpts.com...
20.09.2021	Mirati Therapeutics : Announces Positive Phase 2 Topline Res...	SAN DIEGO, Sept. 20, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage...	marketscre...
20.09.2021	Mirati Therapeutics : Announces Long-term Survival Results f...	SAN DIEGO, Sept. 20, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage...	marketscre...
24.06.2021	Mirati Therapeutics' : Adagrasib Receives Breakthrough Thera...	SAN DIEGO, June 24, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage ...	marketscre...
25.02.2021	Mirati Therapeutics Reports Fourth Quarter And Full-Year 202...	SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage ta...	prnewswire...
25.02.2021	Mirati Therapeutics Reports Fourth Quarter And Full-Year 202...	SAN DIEGO, Feb. 25, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage targ...	oaoa.com/n...
13.02.2021	Another Keytruda combo tops standard of care in advanc...	If you’re a big KRAS G12C fan, mark your calendars for October 28 at 4:20 pm EDT. That’s when Mirat...	endpts.com...
17.09.2020	Boehringer Ingelheim And Mirati Therapeutics Announce Clinic...	INGELHEIM, Germany and SAN DIEGO, Sept. 17, 2020 /PRNewswire/ -- Boehringer Ingelheim and Mirati T...	prnewswire...
06.01.2020	Merck partners with Taiho, Otsuka in $2.5B bet on KRAS-targe...	Financial terms of the deal include a $50 million upfront payment for Taiho and Astex, as well as up...	medcitynew...
29.10.2019	Mirati presents data on drug with tough-to-reach target, set...	Shares of Mirati rose 16.5 percent on the Nasdaq Tuesday morning following the news. Amgen is develo...	medcitynew...
26.04.2019	Celebrating sustained sales growth, AstraZeneca quiet...	While AstraZeneca execs clustered by the front door to discuss their third straight quarter wit...	endpts.com...
22.10.2018	Beyond the headline: Mirati undersells concerning data on it...	Is the clinical and regulatory update Mirati Therapeutics (MRTX) provided Monday for its lead lung c...	statnews.c...
-	Mirati presents data on drug with tough-to-reach target, set...	Amgen’s drug for an “undruggable” cancer target had its first data out earlier this year, but its al...	medcitynew...
-	Built for the challenge of KRASG12C: A new treatment option ...	Non-small cell lung cancer (NSCLC) patients and providers now have a new treatment option following ...	statnews.c...
-	Merck partners with Taiho, Otsuka in $2.5B bet on KRAS-targe...	A Japanese drugmaker is teaming up with subsidiaries of one of the largest pharmaceutical companies ...	medcitynew...
-	Mirati Therapeutics to Present Late-Breaking Data That Advan...	SAN DIEGO, March 10, 2021 /PRNewswire/ -- Mirati Therapeutics, Inc. (NASDAQ: MRTX), a late-stage tar...	oaoa.com/n...